Purinergic signalling: therapeutic developments

G Burnstock - Frontiers in pharmacology, 2017 - frontiersin.org
Purinergic signalling, ie, the role of nucleotides as extracellular signalling molecules, was
proposed in 1972. However, this concept was not well accepted until the early 1990's when …

Historical and current adenosine receptor agonists in preclinical and clinical development

KA Jacobson, DK Tosh, S Jain, ZG Gao - Frontiers in cellular …, 2019 - frontiersin.org
Adenosine receptors (ARs) function in the body's response to conditions of pathology and
stress associated with a functional imbalance, such as in the supply and demand of …

Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations

L Antonioli, C Blandizzi, B Csóka, P Pacher… - Nature reviews …, 2015 - nature.com
Adenosine is a key extracellular signalling molecule that regulates several aspects of tissue
function by activating four G-protein-coupled receptors, A1, A2A, A2B and A1 adenosine …

Wildfire smoke exposure during pregnancy: a review of potential mechanisms of placental toxicity, impact on obstetric outcomes, and strategies to reduce exposure

E Basilio, R Chen, AC Fernandez, AM Padula… - International journal of …, 2022 - mdpi.com
Climate change is accelerating the intensity and frequency of wildfires globally.
Understanding how wildfire smoke (WS) may lead to adverse pregnancy outcomes and …

Exposome and foetoplacental vascular dysfunction in gestational diabetes mellitus

P Valero, G Fuentes, M Cornejo, S Vega… - Molecular Aspects of …, 2022 - Elsevier
A balanced communication between the mother, placenta and foetus is crucial to reach a
successful pregnancy. Several windows of exposure to environmental toxins are present …

The impact of oxidative stress of environmental origin on the onset of placental diseases

CSM Ruano, F Miralles, C Méhats, D Vaiman - Antioxidants, 2022 - mdpi.com
Oxidative stress (OS) plays a pivotal role in placental development; however, abnormal
loads in oxidative stress molecules may overwhelm the placental defense mechanisms and …

Gestational diabetes mellitus placentas exhibit epimutations at placental development genes

LP Meyrueix, R Gharaibeh, J Xue, C Brouwer… - Epigenetics, 2022 - Taylor & Francis
Gestational diabetes mellitus (GDM) is a maternal metabolic disorder that perturbs placental
development and increases the risk of offspring short-and long-term metabolic disorders …

Insulin receptor isoforms: an integrated view focused on gestational diabetes mellitus

F Westermeier, T Sáez, P Arroyo… - Diabetes/metabolism …, 2016 - Wiley Online Library
The human insulin receptor (IR) exists in two isoforms that differ by the absence (IR‐A) or the
presence (IR‐B) of a 12‐amino acid segment encoded by exon 11. Both isoforms are …

[HTML][HTML] Role of insulin, adenosine, and adipokine receptors in the foetoplacental vascular dysfunction in gestational diabetes mellitus

M Subiabre, R Villalobos-Labra, L Silva… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Gestational diabetes mellitus (GDM) is a disease of pregnancy associated with maternal and
foetal hyperglycaemia and altered foetoplacental vascular function. Human foetoplacental …

Adenosine receptors and diabetes: focus on the A2B adenosine receptor subtype

S Merighi, PA Borea, S Gessi - Pharmacological Research, 2015 - Elsevier
Over the last two decades, diabetes mellitus has become one of the most challenging health
problems worldwide. Diabetes mellitus, classified as type I and II, is a pathology concerning …